Skip to content
Subscribe
Billionaire Profile
Habil Khorakiwala
Global Rank
#2196

Habil Khorakiwala

CEO, Pharmaceuticals
Mumbai, India
Real-Time Net Worth
$1.91B
Estimated based on Pharmaceuticals stock value as of September 10, 2026
+1.15% (24h)
Age
83
Source
pharmaceuticals
Industry
Healthcare
Citizenship
India

Biography

Habil Khorakiwala, born in 1942, is the founder and chairman of Wockhardt, a leading Indian pharmaceutical and biotechnology company. With a current estimated net worth of $1.2 billion, Khorakiwala's wealth stems from his pioneering work in the pharmaceuticals industry. His career began in 1967 when he founded Wockhardt, growing it into a global enterprise. His achievements include launching innovative drugs like PROXYVON and BIOVAC-B. He is known for his commitment to philanthropy and his role as an honorary consul general of Sweden in Mumbai.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$1.91B
2025$1.30B
2024$1.20B

Portfolio Holdings

Wockhardt

Wockhardt

WOCKPHARMA•healthcare
Ownership
49.1%
Market Cap
$190M
Stock Price
$1138.8
Revenue
$320M
Mumbai, India
3,000 (2023) employees
Founded 1967

In-Depth Profile

Early Life

Habil Khorakiwala was born in Bombay (now Mumbai) in 1942, into a Dawoodi Bohra family. His father, Fakhruddin T. Khorakiwala, founded the Akbarallys retail chain and was also the former Sheriff of Mumbai.

Rise to Success

Khorakiwala's journey began after he graduated with a pharmacy degree from L.M. College in Ahmedabad and later earned a Master's degree in Pharmaceutical Science from Purdue University, USA. He also attended the Advanced Management Programme at Harvard Business School. In 1967, he founded Wockhardt, transforming it from a small firm into a leading pharmaceutical and biotechnology conglomerate.

Key Business Strategies

Under Khorakiwala's leadership, Wockhardt expanded its operations globally, focusing on research and development. The company has multiple manufacturing facilities and research centers. Key innovations include the launch of PROXYVON, India's first pain management combination drug, and BIOVAC-B, the country's first recombinant hepatitis B vaccine.

Philanthropy

Khorakiwala has been actively involved in philanthropic initiatives through the Wockhardt Foundation. The foundation has touched the lives of millions through its various medical and social programs. He has also been appointed as the Chancellor of Jamia Hamdard University.

Career Milestones

1967

Founded Wockhardt Limited

Established Wockhardt, which grew into a global pharmaceutical and biotechnology company.

1972

Launched PROXYVON

Launched PROXYVON, the first combination formulation in pain management in India.

2000

Launched BIOVAC-B

Launched BIOVAC-B, the first recombinant product in India.

2010

Honorary Doctorate from Purdue University

Awarded an honorary Doctor of Pharmacy degree by Purdue University.

2014

Chancellor of Jamia Hamdard University

Appointed as the Chancellor of Jamia Hamdard University.

Philanthropy & Social Impact

Healthcare

Wockhardt Foundation

Undisclosed

The Wockhardt Foundation runs mobile healthcare units delivering free primary healthcare to rural India.

Business Philosophy & Leadership

Leadership Principles

Customer-Focused

Advocates for a customer-centric approach in all aspects of Wockhardt's operations.

Change Management

Embraces change management to steer Wockhardt towards becoming a leading healthcare group.

Controversies & Challenges

2021

Pandora Papers

Habil Khorakiwala and his family were listed in the Pandora Papers for holding shares worth $20 million in a Panama firm.

Billionaires Connected to Habil Khorakiwala

Peers in Healthcare

All Healthcare billionaires →

Richest in India

All billionaires from India →

Adjacent Global Ranks

Full global ranking →

Compare Habil Khorakiwala

Net Worth Face-off
Habil Khorakiwala vs Elon Musk
Compare Wealth →
Net Worth Face-off
Habil Khorakiwala vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Habil Khorakiwala vs Mark Zuckerberg
Compare Wealth →

Frequently Asked Questions

What is Habil Khorakiwala's net worth in 2026?
As of 2026, Habil Khorakiwala's estimated net worth is $1.906 billion, ranking #2196 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Habil Khorakiwala make their money?
Habil Khorakiwala's wealth primarily comes from pharmaceuticals, most notably through Pharmaceuticals.
Where is Habil Khorakiwala from?
Habil Khorakiwala is from India.
How old is Habil Khorakiwala?
Habil Khorakiwala is 83 years old.

Sources & References

  1. Habil Khorakiwala — Forbes profile — Forbes